Finland vs Israel: The number of people with susceptibility test result for rifampicin
Finland
87
in 2021
Israel
103
in 2021
Finland rank
111th
Israel rank
108th
The number of people with susceptibility test result for rifampicin over time
- Finland
- Israel
How they compare
Israel currently reports 103 against 87 in Finland, a difference of 16.
That makes Israel's figure about 1.2 times Finland's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Finland ahead.
Finland ranks 111th and Israel ranks 108th of 155 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Finland | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 127.33 | 129.33 | 2 | Israel |
| 2020s | 93.5 | 96 | 2.5 | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Finland or Israel?
- Israel, at 103 against 87 in Finland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Finland and Israel?
- 16, with Israel ahead.
- How many years of comparable data are there for Finland and Israel?
- 5 years are reported by both, from 2017 to 2021.
- How do Finland and Israel rank globally for the number of people with susceptibility test result for rifampicin?
- Finland ranks 111th and Israel ranks 108th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.